⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
globenewswire.com
SNY
REGN
MIPI Alliance發表UniPro v3.0和M-PHY v6.0，協助提升行動裝置、PC和汽車領域邊緣AI的JEDEC UFS效能
businesswire.com
GOOGL
QCOM
TXN
MU
INTC
AAPL
MSFT
NVDA
AMZN
ADI
NXPI
STM
ON
AMD
MRVL
AVGO
MCHP
WDC
SE
SMTC
SNPS
AMKR
ALGN
ASML
CDNS
CHKP
CRUS
DLTR
ENPH
ERIC
FSLR
GILD
HPE
IBM
INFY
INTU
KEYS
KHC
LRCX
LULU
MDT
MELI
MNST
MRNA
MSI
NFLX
NTAP
ORCL
PAYX
PEP
PPC
PYPL
REGN
ROST
SBUX
SIRI
SNOW
SRPT
SWKS
TCOM
TDS
TECK
TER
TGT
TMO
TSLA
TTWO
ULTA
VRSK
VRTX
WEC
XEL
XRAY
ZBRA
ZM
ZS
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
REGN
More Than 30 Million Americans Living with Rare Diseases
prnewswire.com
AMGN
SNY
AGIO
ASND
DVA
INCY
NVS
PFE
REGN
UCB
PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascular Access Solutions
prnewswire.com
REGN
AZN
BMY
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX
Omalizumab Triggers T Cell Modification, Increasing the Reaction Thresholds to Common Food Allergens
prnewswire.com
REGN
Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD
globenewswire.com
REGN
No Association Found Between Asthma Biologics and Increased Respiratory Infection Risk
prnewswire.com
REGN